- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Profitable Climbers
Taiwanese Pharmaceuticals & Biotech Profitable Climbers
Results
3
0 new
3 companies
PharmaEssentia
Market Cap: NT$184.9b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$507.00
7D
7.9%
1Y
-22.7%
Lotus Pharmaceutical
Market Cap: NT$71.5b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$280.50
7D
-0.9%
1Y
2.2%
Bora Pharmaceuticals
Market Cap: NT$59.3b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$493.00
7D
1.0%
1Y
-22.6%